Tuesday, 02 January 2024 12:17 GMT

Strategic Intelligence: Medical Devices M&A Deals Report, Q3 2025 - Opportunities In Mega-Deals, With A 39% Increase In Q3 2025 Vs Q3 2024


(MENAFN- GlobeNewsWire - Nasdaq) The medical devices sector presents opportunities in mega-deals, with a 39% increase in Q3 2025 over Q3 2024. This emphasizes the importance of investing in prevailing themes identified through recent M&A activity to capitalize on future market disruptions.

Dublin, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The "Strategic Intelligence: Medical Devices M&A Deals Q3 2025 - Top Themes" report has been added to ResearchAndMarkets's offering.
This report analyzes the disruptive themes that have driven M&A activity in Q3 2025 in the Medical Devices Sector
The global medical devices market witnessed deals worth $34 billion in Q3 2025, a decrease of 2% compared to Q3 2024. The sector recorded deal value worth $29 billion mega-deals (defined as any deal valued at more than $1 billion), an increase of 39% compared to Q3 2024.
Report Scope

  • This report provides an overview of merger and acquisition activity globally in Q3 2025 in Medical Devices Sector
  • It identifies the themes driving most notable to deals announced in Q3 2025 in the Medical Devices Sector

Reasons to Buy

  • Companies who invest in the right themes become success stories; those who miss the big themes end up as failures. If you want to understand the themes that drive an industry, simply look at the list of recent mergers and acquisitions (M&A).
  • In this report we have listed down the most notable deals in medical devices sector to make it easy for our clients to get a view of themes disrupting the sector and prepare for the future.

Key Topics Covered:

  • Executive Summary
  • Review of the Medical Devices M&A Market - Q3 2025
  • Medical Devices M&A Deals Analysis by Geography - Q3 2025
  • Further Reading
  • Report Authors
  • Deal Selection Criteria
  • Thematic Research Methodology

Companies Featured

  • Waters
  • Patient Square Capital LP
  • Alpha JWC Ventures
  • Alpha Wave Ventures
  • Amzak Health
  • Bezos Expeditions LLC
  • Early Stage Partners, LP
  • Hatteras Venture Partners
  • HealthQuest Capital
  • Johnson & Johnson Innovation - JJDC Inc
  • K5 Global
  • Lumira Capital Investment Management Inc
  • State of Michigan Retirement Systems
  • State of Wisconsin Investment Board
  • Venture Investors Health Fund
  • Wellington Management Company LLP
  • Yonjin Venture
  • Cardinal Health Inc
  • Terumo Corp
  • Alcon Inc
  • Waystar Holding Corp
  • Shuaa Capital PSC
  • Qatar Investment Authority
  • ArchiMed SAS
  • Concentra Biosciences LLC
  • Abu Dhabi Investment Authority
  • Zimmer Biomet Holdings Inc
  • Novartis AG
  • AAR Corp
  • Strata Critical Medical Inc
  • Medartis Holding AG
  • Sothema
  • OsteoCentric Technologies Inc
  • Boston Scientific Corp
  • Augusta SpinCo
  • BD
  • Premier Inc
  • HistoSonics Inc
  • Solaris Health Holdings LLC
  • OrganOx, Ltd.
  • STAAR Surgical Co
  • Iodine Software Llc
  • YgEia3 Ltd
  • Kangji Medical Holdings Ltd
  • ZimVie Inc
  • iTeos Therapeutics Inc
  • Micro Life Sciences Private Limited
  • Monogram Technologies Inc
  • Sironax
  • American Distributors Holding Co., LLC
  • Keystone Perfusion Services LLC
  • KeriMedical SA
  • Soludia Maghreb
  • Integrum AB
  • Elutia

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN01122025004107003653ID1110420159



GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search